chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, SARS-CoV-2 test: negative Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment or concomitant medications were reported. Experienced mild flu-like symptoms. Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: TCR Form - patient declined further follow-up, provided event outcome.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: Swelling gland under the ear; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling gland under the ear) and PAIN IN EXTREMITY (Sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced LYMPHADENOPATHY (Swelling gland under the ear) and PAIN IN EXTREMITY (Sore arm). At the time of the report, LYMPHADENOPATHY (Swelling gland under the ear) and PAIN IN EXTREMITY (Sore arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not reported.  Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Reporter said Everything is Fine now. Declined to share Email address
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Illness, Influenza like illness, Malaise, Pyrexia
Clinical narrative: He started to not feel well again today; Sunday got sicker; had diarrhea; Had a fever of 99.5; Flu like symptoms; This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), ILLNESS (Sunday got sicker), DIARRHOEA (had diarrhea), MALAISE (He started to not feel well again today) and PYREXIA (Had a fever of 99.5) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (Had a fever of 99.5). On 07-Feb-2021, the patient experienced ILLNESS (Sunday got sicker) and DIARRHOEA (had diarrhea). On 09-Feb-2021, the patient experienced MALAISE (He started to not feel well again today). The patient was treated with LOPERAMIDE in February 2021 for Diarrhea, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) 06-Feb-2021 for Fever, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), ILLNESS (Sunday got sicker), DIARRHOEA (had diarrhea), MALAISE (He started to not feel well again today) and PYREXIA (Had a fever of 99.5) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: little pain; Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little pain) and VACCINATION SITE PAIN (Tenderness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (little pain) and VACCINATION SITE PAIN (Tenderness). At the time of the report, VACCINATION SITE PAIN (little pain) and VACCINATION SITE PAIN (Tenderness) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not reported.  Treatment medication was not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: two red circles bruised around at the injection site, each circle is like 3 inches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (two red circles bruised around at the injection site, each circle is like 3 inches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE BRUISING (two red circles bruised around at the injection site, each circle is like 3 inches). At the time of the report, VACCINATION SITE BRUISING (two red circles bruised around at the injection site, each circle is like 3 inches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Mammogram
Clinical narrative: swollen lymph node developed; Headache; I was tired; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 032L2*A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (To Amifostine 20 years ago). Previously administered products included for an unreported indication: AMIFOSTINE (20 years ago). Concurrent medical conditions included Cancer. Concomitant products included OLAPARIB (LYNPARZA) for Cancer.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired). At the time of the report, LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: swollen lymph node.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Treatment medication was not reported.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: Mild Itching on the face; hives on the face; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Mild Itching on the face) and URTICARIA (hives on the face) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced RASH PRURITIC (Mild Itching on the face) and URTICARIA (hives on the face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in February 2021 for Rash and Hives, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Mild Itching on the face) and URTICARIA (hives on the face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.   Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash at injection site, spread out, has got wider; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site, spread out, has got wider) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041l20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included GABAPENTIN, ROSUVASTATIN, METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), LEVOTHYROXINE, PROPRANOLOL, SERTRALINE, PALIPERIDONE and CLONAZEPAM for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site, spread out, has got wider). At the time of the report, VACCINATION SITE RASH (Rash at injection site, spread out, has got wider) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Feels sleepy; Developed itchy mark injection site; Developed red mark on injection site; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Feels sleepy), VACCINATION SITE PRURITUS (Developed itchy mark injection site) and VACCINATION SITE ERYTHEMA (Developed red mark on injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced SOMNOLENCE (Feels sleepy), VACCINATION SITE PRURITUS (Developed itchy mark injection site) and VACCINATION SITE ERYTHEMA (Developed red mark on injection site). At the time of the report, SOMNOLENCE (Feels sleepy), VACCINATION SITE PRURITUS (Developed itchy mark injection site) and VACCINATION SITE ERYTHEMA (Developed red mark on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Phone contact, patient hung up phone.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Pain in extremity
Clinical narrative: arthritis of the knee; Very severe pain from her knees to feet, on both legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very severe pain from her knees to feet, on both legs) and ARTHRITIS (arthritis of the knee) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Very severe pain from her knees to feet, on both legs). On an unknown date, the patient experienced ARTHRITIS (arthritis of the knee). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Very severe pain from her knees to feet, on both legs) and ARTHRITIS (arthritis of the knee) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable. No relevant concomitant medications reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: TCR attached. Event updated.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysphonia, Throat clearing, Throat irritation
Clinical narrative: Irritated throat; Coughing; Voice was a little gravely; clearing her throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Irritated throat), COUGH (Coughing), DYSPHONIA (Voice was a little gravely) and THROAT CLEARING (clearing her throat) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Bee sting.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced THROAT IRRITATION (Irritated throat), COUGH (Coughing), DYSPHONIA (Voice was a little gravely) and THROAT CLEARING (clearing her throat). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in January 2021 for Adverse event, at an unspecified dose and frequency. In January 2021, THROAT IRRITATION (Irritated throat), COUGH (Coughing), DYSPHONIA (Voice was a little gravely) and THROAT CLEARING (clearing her throat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: No new event information received. Information provided included address, email address, and correct spelling of last name.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium, Blood sodium, Chills, Decreased appetite, Headache
Clinical narrative: Heart started racing; She had tachycardia; Her appetite is down; Sweating palms; nausea; Headache; Fever; Chills for 2 days; This spontaneous case was reported by a physician assistant and describes the occurrence of PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and HEADACHE (Headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FEXOFENADINE, MELATONIN and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills for 2 days). On 30-Jan-2021, the patient experienced PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) on 28-Jan-2021 for Chills, Fever and Headache, at an unspecified dose and frequency. On 30-Jan-2021, HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills for 2 days) had resolved. At the time of the report, PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Blood potassium: low (Low) Low. On 30-Jan-2021, Blood sodium: low (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medication included unspecified birth control.   Reporter did not allow further contact
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Palpitations, Pyrexia, Tachycardia
Clinical narrative: Heart started racing; She had tachycardia; Her appetite is down; Sweating palms; nausea; Headache; Fever; Chills for 2 days; This spontaneous case was reported by a physician assistant and describes the occurrence of PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and HEADACHE (Headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FEXOFENADINE, MELATONIN and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills for 2 days). On 30-Jan-2021, the patient experienced PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) on 28-Jan-2021 for Chills, Fever and Headache, at an unspecified dose and frequency. On 30-Jan-2021, HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills for 2 days) had resolved. At the time of the report, PALPITATIONS (Heart started racing), TACHYCARDIA (She had tachycardia), DECREASED APPETITE (Her appetite is down), HYPERHIDROSIS (Sweating palms) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Jan-2021, Blood potassium: low (Low) Low. On 30-Jan-2021, Blood sodium: low (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medication included unspecified birth control.   Reporter did not allow further contact
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin disorder, Vaccination site pain
Clinical narrative: Itching; Forehead Rash/Face Rash/Shoulders Rash/Chest Rash/Rash on his Bald head; prickly bumps on top of Head; Pain on Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISORDER (prickly bumps on top of Head), PRURITUS (Itching), RASH (Forehead Rash/Face Rash/Shoulders Rash/Chest Rash/Rash on his Bald head) and VACCINATION SITE PAIN (Pain on Injection Site) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain on Injection Site). On 08-Feb-2021, the patient experienced SKIN DISORDER (prickly bumps on top of Head) and RASH (Forehead Rash/Face Rash/Shoulders Rash/Chest Rash/Rash on his Bald head). On 09-Feb-2021, the patient experienced PRURITUS (Itching). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Itching, at a dose of 1 dosage form. At the time of the report, SKIN DISORDER (prickly bumps on top of Head), PRURITUS (Itching), RASH (Forehead Rash/Face Rash/Shoulders Rash/Chest Rash/Rash on his Bald head) and VACCINATION SITE PAIN (Pain on Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment for the event included topical steroids began 10-FEB-2021.  Patient gave consent for safety to Follow-up.
Sex: F
Vaccine: COVID19
Symptoms: Coronavirus test, Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 08-Feb-2021.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Coronavirus test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heartbeat is rising) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced HEART RATE INCREASED (heartbeat is rising). At the time of the report, HEART RATE INCREASED (heartbeat is rising) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not reported. Treatment medication was not reported
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Fatigue; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011KL20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site). On 16-Jan-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. On 18-Jan-2021, FATIGUE (Fatigue) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medication was not reported.  Treatment medication was not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Telephone contact in attempt to obtain email address, reporter disconnected the call.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inflammation, Rash erythematous, Sensitive skin, Vaccination site erythema
Clinical narrative: ERYTHEMATOUS; LOCALIZED INFLAMMATION; Arm is sensitive; hot; hives; red ring going around; arm was red; arm was tender; slight headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (ERYTHEMATOUS), INFLAMMATION (LOCALIZED INFLAMMATION), SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot) and VACCINATION SITE URTICARIA (hives) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010MZU(orV)7) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Diabetes, High cholesterol, Drug allergy (Most cholesterol medicines, hydrocodone allergy), Food allergy (scallops, clams, bass, fish) and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 25-Feb-2021, the patient experienced SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot), VACCINATION SITE URTICARIA (hives), VACCINATION SITE RASH (red ring going around), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PAIN (arm was tender) and HEADACHE (slight headache). On 26-Feb-2021, the patient experienced RASH ERYTHEMATOUS (ERYTHEMATOUS) and INFLAMMATION (LOCALIZED INFLAMMATION). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; HYDROCORTISONE for Adverse event, at an unspecified dose and frequency and HYDROXYZINE for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (ERYTHEMATOUS), INFLAMMATION (LOCALIZED INFLAMMATION), SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot), VACCINATION SITE URTICARIA (hives), VACCINATION SITE RASH (red ring going around), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PAIN (sore arm), VACCINATION SITE PAIN (arm was tender) and HEADACHE (slight headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: ERYTHEMATOUS; LOCALIZED INFLAMMATION; Arm is sensitive; hot; hives; red ring going around; arm was red; arm was tender; slight headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (ERYTHEMATOUS), INFLAMMATION (LOCALIZED INFLAMMATION), SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot) and VACCINATION SITE URTICARIA (hives) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010MZU(orV)7) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Diabetes, High cholesterol, Drug allergy (Most cholesterol medicines, hydrocodone allergy), Food allergy (scallops, clams, bass, fish) and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 25-Feb-2021, the patient experienced SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot), VACCINATION SITE URTICARIA (hives), VACCINATION SITE RASH (red ring going around), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PAIN (arm was tender) and HEADACHE (slight headache). On 26-Feb-2021, the patient experienced RASH ERYTHEMATOUS (ERYTHEMATOUS) and INFLAMMATION (LOCALIZED INFLAMMATION). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency; HYDROCORTISONE for Adverse event, at an unspecified dose and frequency and HYDROXYZINE for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (ERYTHEMATOUS), INFLAMMATION (LOCALIZED INFLAMMATION), SENSITIVE SKIN (Arm is sensitive), VACCINATION SITE WARMTH (hot), VACCINATION SITE URTICARIA (hives), VACCINATION SITE RASH (red ring going around), VACCINATION SITE ERYTHEMA (arm was red), VACCINATION SITE PAIN (sore arm), VACCINATION SITE PAIN (arm was tender) and HEADACHE (slight headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Itching at the injection site; headaches; Redness at the injection site; Swelling at the injection site; Fatigue; muscle pain; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and FATIGUE (Fatigue) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (esophageal). Concomitant products included OMEPRAZOLE for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), FATIGUE (Fatigue), MYALGIA (muscle pain), CHILLS (chills) and NAUSEA (nausea). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), FATIGUE (Fatigue), MYALGIA (muscle pain), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching at the injection site; headaches; Redness at the injection site; Swelling at the injection site; Fatigue; muscle pain; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and FATIGUE (Fatigue) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acid reflux (esophageal). Concomitant products included OMEPRAZOLE for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), FATIGUE (Fatigue), MYALGIA (muscle pain), CHILLS (chills) and NAUSEA (nausea). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (headaches), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), FATIGUE (Fatigue), MYALGIA (muscle pain), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered from a vial punctured more than 18 hours ago; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial punctured more than 18 hours ago) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial punctured more than 18 hours ago). On 11-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered from a vial punctured more than 18 hours ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pyrexia
Clinical narrative: Dizziness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Vertigo.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (Fever). On 05-Feb-2021, the patient experienced DIZZINESS (Dizziness). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] on 04-Feb-2021 for Fever, at an unspecified dose and frequency. On 05-Feb-2021, PYREXIA (Fever) had resolved. At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Erythema, Vaccination site pruritus
Clinical narrative: soreness on the inside of her arm; Extreme itching on the arm where the vaccine was given; Big red flat spots from the arm pit to 3 inches below the elbow; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Big red flat spots from the arm pit to 3 inches below the elbow), AXILLARY PAIN (soreness on the inside of her arm) and VACCINATION SITE PRURITUS (Extreme itching on the arm where the vaccine was given) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (Right side) and Lymph node excision. Concurrent medical conditions included Metastatic breast cancer. Concomitant products included CAPECITABINE (XELODA) for Metastatic breast cancer.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced ERYTHEMA (Big red flat spots from the arm pit to 3 inches below the elbow) and VACCINATION SITE PRURITUS (Extreme itching on the arm where the vaccine was given). On 06-Feb-2021, the patient experienced AXILLARY PAIN (soreness on the inside of her arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in February 2021 for Itching and Redness, at an unspecified dose and frequency. On 08-Feb-2021, ERYTHEMA (Big red flat spots from the arm pit to 3 inches below the elbow) had resolved. At the time of the report, AXILLARY PAIN (soreness on the inside of her arm) and VACCINATION SITE PRURITUS (Extreme itching on the arm where the vaccine was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: A rash on her left leg that was itchy and spread more; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (A rash on her left leg that was itchy and spread more) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038k20a and 013m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced RASH PRURITIC (A rash on her left leg that was itchy and spread more). At the time of the report, RASH PRURITIC (A rash on her left leg that was itchy and spread more) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not reported.  Treatment included unspecified cream.   This case was linked to MOD-2021-027643.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Dyspnoea, Feeling abnormal, Vertigo
Clinical narrative: Vertigo; Foggy headed; Shortness of breath; Dizzy spells; Feels off balance; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), FEELING ABNORMAL (Foggy headed), DYSPNOEA (Shortness of breath), DIZZINESS (Dizzy spells) and BALANCE DISORDER (Feels off balance) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M02A) for COVID-19 vaccination.     The patient's past medical history included Polio (As a child). Concomitant products included SERTRALINE for an unknown indication.  On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VERTIGO (Vertigo), FEELING ABNORMAL (Foggy headed), DYSPNOEA (Shortness of breath), DIZZINESS (Dizzy spells) and BALANCE DISORDER (Feels off balance). The patient was treated with MECLIZINE [MECLOZINE] for Adverse event, at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo), FEELING ABNORMAL (Foggy headed), DYSPNOEA (Shortness of breath), DIZZINESS (Dizzy spells) and BALANCE DISORDER (Feels off balance) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Additional treatment medications included jinger and Claritin which the patient did not take.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Fatigue, Nausea, Pain
Clinical narrative: Shortness of breath; Full body aches; Cannot recovery any energy; Extreme exhaustion; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Full body aches), ASTHENIA (Cannot recovery any energy), FATIGUE (Extreme exhaustion) and NAUSEA (Nausea) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Migraine and Headache. Concomitant products included TOPIRAMATE (TOPAMAX) and SUMATRIPTAN SUCCINATE (IMITREX DF) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Full body aches), ASTHENIA (Cannot recovery any energy), FATIGUE (Extreme exhaustion) and NAUSEA (Nausea). At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Full body aches), ASTHENIA (Cannot recovery any energy), FATIGUE (Extreme exhaustion) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.   This case was linked to MOD-2021-223730 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Headache; Slightly sore arm; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (Headache) and VACCINATION SITE PAIN (Slightly sore arm) in a 69-year-old female patient who received mRNA-1273 (batch nos. 012L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (Slightly sore arm). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) and VACCINATION SITE PAIN (Slightly sore arm) had resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.   This case was linked to MOD-2021-223785 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting of bile; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting of bile) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VOMITING (Vomiting of bile). At the time of the report, VOMITING (Vomiting of bile) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported. No treatment was taken.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nausea
Clinical narrative: cannot lift injection arm; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (cannot lift injection arm) and NAUSEA (nauseous) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (cannot lift injection arm) and NAUSEA (nauseous). At the time of the report, MUSCULOSKELETAL STIFFNESS (cannot lift injection arm) and NAUSEA (nauseous) outcome was unknown.            Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Body aches; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 for Chills, Generalised muscle aches and Fever, at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication was not reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Muscle spasms, Myalgia, Pain in extremity
Clinical narrative: arm was a little sore for a couple days, sore arm; felt like I had a spasm in my leg it was horrible; muscles in my legs were just killing me, muscle pain; every joint in my body are killing me today, joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore for a couple days, sore arm), MUSCLE SPASMS (felt like I had a spasm in my leg it was horrible), MYALGIA (muscles in my legs were just killing me, muscle pain) and ARTHRALGIA (every joint in my body are killing me today, joint pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MUSCLE SPASMS (felt like I had a spasm in my leg it was horrible), MYALGIA (muscles in my legs were just killing me, muscle pain) and ARTHRALGIA (every joint in my body are killing me today, joint pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was a little sore for a couple days, sore arm). At the time of the report, PAIN IN EXTREMITY (arm was a little sore for a couple days, sore arm) and MUSCLE SPASMS (felt like I had a spasm in my leg it was horrible) outcome was unknown and MYALGIA (muscles in my legs were just killing me, muscle pain) and ARTHRALGIA (every joint in my body are killing me today, joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood thinners, medication for blood pressure and heart medication. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Pruritus, Rash
Clinical narrative: on her right leg little red pimples that were itchy; a rash on her left leg that was itchy and spread more; rash on her left leg that was itchy and spread more; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (on her right leg little red pimples that were itchy), RASH (a rash on her left leg that was itchy and spread more) and PRURITUS (rash on her left leg that was itchy and spread more) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013m20a and 038k20a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced PRURITUS (rash on her left leg that was itchy and spread more). On 23-Feb-2021, the patient experienced ACNE (on her right leg little red pimples that were itchy) and RASH (a rash on her left leg that was itchy and spread more). At the time of the report, ACNE (on her right leg little red pimples that were itchy), RASH (a rash on her left leg that was itchy and spread more) and PRURITUS (rash on her left leg that was itchy and spread more) outcome was unknown.            concomitants- High blood pressure pills treatment- "Cream" didn't remember which Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.